Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin [see comments]
RS Negrin(Stanford University), PL Greenberg(Stanford University), Ross S. Stein(United States Geological Survey), Jordan Cornwell(Stanford University), Susan E. Krantz(Stanford University), J W Vardiman(University of Chicago Medical Center), Kathleen Doherty(Stanford University)
Cited by 155
Related Papers
Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model
|British Journal of Haematology|1997|314
Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells
|Blood|1996|193
Comparison of the 1959 Hebgen Lake, Montana and the 1983 Borah Peak, Idaho, earthquakes from geodetic observations
|Bulletin of the Seismological Society of America|1989|82